- Project Title
- Foods for diabetes and cognition
- Project Type
- Nacional / Public
- Funding Body
- Funding Program
- H2020 MSCA-RISE-2017 - Marie Skłodowska-Curie Research and Innovation Staff Exchange
- CEB: 45 000,00
- Total: 432 000,00
- INL, UMinho (PT), ULund (SE), Univ. of Reading (UK), SONAE (PT), ANFACO-CEC (ES), A&R House BCL (UK), Universita Cattolica Del Sacro Cuore (IT), DECORGERL SA (PT), CSIC (ES), Bioinicia SL (ES), EVRA S.R.L (IT), GERIATROS SA (ES), Casa EMMA (IT), UCP (PT)
- External link
- Internal link
FODIAC aims to develop a dietary solution to tackle type 2 diabetes and cognitive dysfunction of the elderly. FODIAC will enhance the quality of R&I in Europe, promoting cooperation along the Food Value Chain. This is achieved through advanced international, intersectoral, cooperation between 7 academic and 8 industry partners. For this purpose, FODIAC assembles a European multi/interdisciplinary consortium, composed of partners in 5 countries that provide expertise in: extraction and purification of bioactive molecules, nanotechnology, nano/micro-encapsulation, toxicology, nutrition, biomarkers, clinical trial management.
Rationale: lack of knowledge sharing among academia and industry acts as a barrier for the development of functional foods for the elderly, who represent one of the fastest-growing population segments worldwide.
Approach and Outcomes: FODIAC coordinates the actions of individual partners, academic and industrial, using Exchange of Staff as a tool to capitalize on complementary competences to: i) conduct joint research; ii) protect the Intellectual Property based on this research; iii) foster the transference of the generated knowledge, skills, and technology to the industrial sector; and iv) exploit research output to the benefit of society. FODIAC’s outcomes will include: i) an increase in the R&I capacity among participating partners; ii) boosting of knowledge transfer of emerging micro/nano-biotechnologies from academia to industry, to develop cost-effective processes; iii) commercialization of new functional ingredients and functional foods containing antidiabetic and cognitive-enhancing bioactive molecules; iv) acceleration of the development of dietary recommendations and interventions based on those products, to improve the quality of life of the elderly; iv) a sustainable research network of academic and industrial partners and v) the leveraging of career perspectives of individual researchers, both in and outside academic institution